BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zekri AR, Youssef AS, Lotfy MM, Gabr R, Ahmed OS, Nassar A, Hussein N, Omran D, Medhat E, Eid S, Hussein MM, Ismail MY, Alenzi FQ, Bahnassy AA. Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer. PLoS One 2016;11:e0154130. [PMID: 27135244 DOI: 10.1371/journal.pone.0154130] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Chan SCH, Liang JQ. Advances in tests for colorectal cancer screening and diagnosis. Expert Rev Mol Diagn 2022. [PMID: 35400293 DOI: 10.1080/14737159.2022.2065197] [Reference Citation Analysis]
2 Huang X, Zhu X, Yu Y, Zhu W, Jin L, Zhang X, Li S, Zou P, Xie C, Cui R. Dissecting miRNA signature in colorectal cancer progression and metastasis. Cancer Lett 2021;501:66-82. [PMID: 33385486 DOI: 10.1016/j.canlet.2020.12.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pan C, Yan X, Li H, Huang L, Yin M, Yang Y, Gao R, Hong L, Ma Y, Shi C. Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancer. Oncotarget. 2017;8:68317-68328. [PMID: 28978119 DOI: 10.18632/oncotarget.19344] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
4 Wang JJ, Wang X, Song YX, Zhao JH, Sun JX, Shi JX, Wu ZH, Wang ZN. Circulating Noncoding RNAs Have a Promising Future Acting as Novel Biomarkers for Colorectal Cancer. Dis Markers 2019;2019:2587109. [PMID: 31275444 DOI: 10.1155/2019/2587109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Temilola DO, Wium M, Coulidiati TH, Adeola HA, Carbone GM, Catapano CV, Zerbini LF. The Prospect and Challenges to the Flow of Liquid Biopsy in Africa. Cells 2019;8:E862. [PMID: 31404988 DOI: 10.3390/cells8080862] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
6 Bobbili MR, Mader RM, Grillari J, Dellago H. OncomiR-17-5p: alarm signal in cancer? Oncotarget 2017;8:71206-22. [PMID: 29050357 DOI: 10.18632/oncotarget.19331] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
7 Min L, Chen L, Liu S, Yu Y, Guo Q, Li P, Zhu S. Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage. Int J Med Sci. 2019;16:1231-1237. [PMID: 31588188 DOI: 10.7150/ijms.34540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
8 Rubio J, Cristóbal I, Santos A, Caramés C, Luque M, Sanz-Alvarez M, Zazo S, Madoz-Gúrpide J, Rojo F, García-Foncillas J. Low MicroRNA-19b Expression Shows a Promising Clinical Impact in Locally Advanced Rectal Cancer. Cancers (Basel) 2021;13:1456. [PMID: 33810186 DOI: 10.3390/cancers13061456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Cancer 2018;124:785-96. [PMID: 29112225 DOI: 10.1002/cncr.31062] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
10 Sakha S, Muramatsu T, Ueda K, Inazawa J. Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Sci Rep 2016;6. [DOI: 10.1038/srep38750] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 14.8] [Reference Citation Analysis]
11 Moody L, Dvoretskiy S, An R, Mantha S, Pan YX. The Efficacy of miR-20a as a Diagnostic and Prognostic Biomarker for Colorectal Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel) 2019;11:E1111. [PMID: 31382594 DOI: 10.3390/cancers11081111] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
12 Marcuello M, Vymetalkova V, Neves RPL, Duran-Sanchon S, Vedeld HM, Tham E, van Dalum G, Flügen G, Garcia-Barberan V, Fijneman RJ, Castells A, Vodicka P, Lind GE, Stoecklein NH, Heitzer E, Gironella M. Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol Aspects Med 2019;69:107-22. [PMID: 31189073 DOI: 10.1016/j.mam.2019.06.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 21.7] [Reference Citation Analysis]
13 Sastre D, Baiochi J, de Souza Lima IM, Canto de Souza F, Corveloni AC, Thomé CH, Faça VM, Schiavinato JLDS, Covas DT, Panepucci RA. Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer. BMC Cancer 2019;19:1239. [PMID: 31864341 DOI: 10.1186/s12885-019-6468-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
14 Zhu M, Huang Z, Zhu D, Zhou X, Shan X, Qi LW, Wu L, Cheng W, Zhu J, Zhang L, Zhang H, Chen Y, Zhu W, Wang T, Liu P. A panel of microRNA signature in serum for colorectal cancer diagnosis. Oncotarget 2017;8:17081-91. [PMID: 28177881 DOI: 10.18632/oncotarget.15059] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 13.2] [Reference Citation Analysis]
15 Gurer T, Aytekin A, Caki E, Gezici S. miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of Colorectal Cancer. Mol Biol. [DOI: 10.1134/s0026893322030062] [Reference Citation Analysis]
16 Grassi A, Perilli L, Albertoni L, Tessarollo S, Mescoli C, Urso EDL, Fassan M, Rugge M, Zanovello P. A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer. Mol Cancer 2018;17:17. [PMID: 29386021 DOI: 10.1186/s12943-018-0770-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
17 Li H, Wu Q, Li T, Liu C, Xue L, Ding J, Shi Y, Fan D. The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review. Oncotarget 2017;8:45060-71. [PMID: 28178677 DOI: 10.18632/oncotarget.15023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
18 Cao L, Wang J, Wang PQ. MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma. Biomed Pharmacother 2016;84:828-35. [PMID: 27723574 DOI: 10.1016/j.biopha.2016.10.008] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
19 Xiao Z, Chen S, Feng S, Li Y, Zou J, Ling H, Zeng Y, Zeng X. Function and mechanisms of microRNA-20a in colorectal cancer. Exp Ther Med 2020;19:1605-16. [PMID: 32104211 DOI: 10.3892/etm.2020.8432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wan TM, Iyer DN, Ng L. Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer. Histol Histopathol 2020;35:225-37. [PMID: 31617575 DOI: 10.14670/HH-18-171] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
21 Elghoroury EA, Abdelghaffar EE, Awadallah E, Kamel SA, Kandil D, Hassan EM, Hassan M, Kamel MM, Gomaa MM, Fathalla LA. Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma. Int J Immunopathol Pharmacol 2022;36:3946320221097832. [PMID: 35467432 DOI: 10.1177/03946320221097832] [Reference Citation Analysis]
22 Roy JW, Taylor CA, Beauregard AP, Dhadi SR, Ayre DC, Fry S, Chacko S, Wajnberg G, Joy AP, Mai-Thi NN, Crapoulet N, Barnett DA, Ghosh A, Lewis SM, Ouellette RJ. A multiparametric extraction method for Vn96-isolated plasma extracellular vesicles and cell-free DNA that enables multi-omic profiling. Sci Rep 2021;11:8085. [PMID: 33850235 DOI: 10.1038/s41598-021-87526-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Kolenda T, Guglas K, Baranowski D, Sobocińska J, Kopczyńska M, Teresiak A, Bliźniak R, Lamperska K. cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already? Rep Pract Oncol Radiother 2020;25:783-92. [PMID: 32904167 DOI: 10.1016/j.rpor.2020.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Tsukamoto M, Iinuma H, Yagi T, Matsuda K, Hashiguchi Y. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer. Oncology. 2017;92:360-370. [PMID: 28376502 DOI: 10.1159/000463387] [Cited by in Crossref: 92] [Cited by in F6Publishing: 97] [Article Influence: 18.4] [Reference Citation Analysis]
25 El-Daly SM, Morsy SM, Medhat D, El-Bana MA, Latif YA, Omara EA, Awadallah JR, Gamal-Eldeen AM. The diagnostic efficacy of circulating miRNAs in monitoring the early development of colitis-induced colorectal cancer. J Cell Biochem 2019;120:16668-80. [PMID: 31095784 DOI: 10.1002/jcb.28925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Zhang L, Shan X, Wang J, Zhu J, Huang Z, Zhang H, Zhou X, Cheng W, Shu Y, Zhu W, Liu P. A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients. Oncotarget 2017;8:86897-907. [PMID: 29156844 DOI: 10.18632/oncotarget.19666] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
27 Liu GL, Yang HJ, Liu B, Liu T. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway. J Cell Biochem 2017;118:3424-34. [PMID: 28322459 DOI: 10.1002/jcb.25999] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
28 Hibner G, Kimsa-Furdzik M, Francuz T. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer. Int J Mol Sci 2018;19:E2944. [PMID: 30262723 DOI: 10.3390/ijms19102944] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
29 Liu X, Xu T, Hu X, Chen X, Zeng K, Sun L, Wang S. Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer. Cancer Manag Res. 2018;10:857-865. [PMID: 29731665 DOI: 10.2147/cmar.s158016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
30 Rapado-González Ó, Álvarez-Castro A, López-López R, Iglesias-Canle J, Suárez-Cunqueiro MM, Muinelo-Romay L. Circulating microRNAs as Promising Biomarkers in Colorectal Cancer. Cancers (Basel) 2019;11:E898. [PMID: 31252648 DOI: 10.3390/cancers11070898] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
31 Makondi PT, Wei PL, Huang CY, Chang YJ. Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach. PLoS One 2019;14:e0211968. [PMID: 30807603 DOI: 10.1371/journal.pone.0211968] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
32 Moridikia A, Mirzaei H, Sahebkar A, Salimian J. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. J Cell Physiol. 2018;233:901-913. [PMID: 28092102 DOI: 10.1002/jcp.25801] [Cited by in Crossref: 107] [Cited by in F6Publishing: 108] [Article Influence: 21.4] [Reference Citation Analysis]
33 Kolenda T, Guglas K, Kopczyńska M, Sobocińska J, Teresiak A, Bliźniak R, Lamperska K. Good or not good: Role of miR-18a in cancer biology. Rep Pract Oncol Radiother 2020;25:808-19. [PMID: 32884453 DOI: 10.1016/j.rpor.2020.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
34 Horsburgh S, Fullard N, Roger M, Degnan A, Todryk S, Przyborski S, O'Reilly S. MicroRNAs in the skin: role in development, homoeostasis and regeneration. Clin Sci (Lond) 2017;131:1923-40. [PMID: 28705953 DOI: 10.1042/CS20170039] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
35 Marcuello M, Duran-Sanchon S, Moreno L, Lozano JJ, Bujanda L, Castells A, Gironella M. Analysis of A 6-Mirna Signature in Serum from Colorectal Cancer Screening Participants as Non-Invasive Biomarkers for Advanced Adenoma and Colorectal Cancer Detection. Cancers (Basel) 2019;11:E1542. [PMID: 31614785 DOI: 10.3390/cancers11101542] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
36 Asadi M, Talesh ST, Gjerstorff MF, Shanehbandi D, Baradaran B, Hashemzadeh S, Zafari V. Identification of miRNAs correlating with stage and progression of colorectal cancer. Colorectal Cancer 2019;8:CRC06. [DOI: 10.2217/crc-2018-0014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
37 Bader El Din NG, Ibrahim MK, El‐shenawy R, Salum GM, Farouk S, Zayed N, Khairy A, El Awady M. MicroRNAs expression profiling in Egyptian colorectal cancer patients. IUBMB Life 2019;72:275-84. [DOI: 10.1002/iub.2164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
38 Huang Z, Zhang L, Zhu D, Shan X, Zhou X, Qi LW, Wu L, Zhu J, Cheng W, Zhang H, Chen Y, Zhu W, Wang T, Liu P. A novel serum microRNA signature to screen esophageal squamous cell carcinoma. Cancer Med. 2017;6:109-119. [PMID: 28035762 DOI: 10.1002/cam4.973] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 7.2] [Reference Citation Analysis]
39 Crigna AT, Samec M, Koklesova L, Liskova A, Giordano FA, Kubatka P, Golubnitschaja O. Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope? EPMA J 2020;:1-25. [PMID: 33144898 DOI: 10.1007/s13167-020-00226-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
40 Pesta M, Kucera R, Topolcan O, Karlikova M, Houfkova K, Polivka J, Macanova T, Machova I, Slouka D, Kulda V. Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients. Cancers (Basel) 2019;11:E864. [PMID: 31234350 DOI: 10.3390/cancers11060864] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
41 Salah M, Shaheen I, El-Shanawany P, Saad NE, Saad R, El Guibaly M, Momen N. Detection of miR-1246, miR-23a and miR-451 in sera of colorectal carcinoma patients: a case-control study in Cairo University hospital. Afr Health Sci 2020;20:1283-91. [PMID: 33402976 DOI: 10.4314/ahs.v20i3.33] [Reference Citation Analysis]
42 Tito C, De Falco E, Rosa P, Iaiza A, Fazi F, Petrozza V, Calogero A. Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma. Genes (Basel) 2021;12:1154. [PMID: 34440329 DOI: 10.3390/genes12081154] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]